Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls

Nicotine and Tobacco Research

Volumn 17, Issue 5, 2015, Pages 510-514

  Ahnallen, Christopher G ^a,b   Bidwell, L Cinnamon ^c   Tidey, Jennifer W ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE PATCH; NICOTINE; NICOTINE GUM;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MOTOR ACTIVITY; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING; VERY LOW NICOTINE CONTENT CIGARETTE; WORKING MEMORY; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; PSYCHOLOGY; SHORT TERM MEMORY; SMOKING CESSATION; TOBACCO; TOBACCO USE DISORDER; YOUNG ADULT;

ADULT; COGNITION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NICOTINE; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO PRODUCTS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84929149830     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu163     Document Type: Article

References (29)

1. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150:1115-1121.
2. McClave AK, Whitney N, Thorne SL, et al. Adult tobacco survey-19 States, 2003-2007. MMWR Surveill Summ. 2010;59:1-75. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5903a1.htm. Accessed April 3, 2014.
3. Wing VC, Wass CE, Soh DW, George TP. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann N Y Acad Sci. 2012;1248:89-106.
4. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426-445.
5. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153:321-330.
6. George TP, Vessicchio JC, Termine A, et al. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology. 2002;26:75-85.
7. Sacco KA, Termine A, Seyal A, et al. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia. Arch Gen Psychiatry. 2005;62:649-659.
8. Weinberger AH, Creeden CL, Sacco KA, George TP. Neurocognitive effects of nicotine and tobacco in individuals with schizophrenia. J Dual Diagn. 2007;3:61-77.
9. United States Congress. House Committee on Energy and Commerce. Family Smoking Prevention and Tobacco Control Act (H.R. 1256). Washington: U.S. G.P.O, 2009.
10. Ashley DL, Backinger CL, van Bemmel DM, Neveleff DJ. Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products. Nicotine Tob Res. 2014;16:1045-1049.
11. Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994;331:123-125.
12. Hatsukami DK, Benowitz NL, Donny E, Henningfield J, Zeller M. Nicotine reduction: strategic research plan. Nicotine Tob Res. 2013;15:1003-1013.
13. Smith RC, Singh A, Infante M, Khandat A, Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology. 2002;27:479-497.
14. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, AhnAllen CG. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res. 2013;15:121-129. doi: 10.1093/ntr/nts098
15. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
16. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV axis-I Disorders-non-patient edition. New York: Biometric Research Department, 1994.
17. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
18. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Adolfo AB. Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res. 2008;10:1047-1056.
19. Conners CK, MHS Staff, editors. Conners' Continuous Performance Test II: computer program for windows technical guide and software manual. North Tonawanda, NY: Multi-Health Systems, 2000.
20. Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD. Assessing cognitive function in clinical trials in schizophrenia. Neurosci Biobehav Rev. 2010;34:1161-1177.
21. Chamberlain SR, Odlaug BL, Schreiber LRN, Grant JE. Association between tobacco smoking and cognitive functioning in young adults. Am J Addict. 2012;21:S14-S19.
22. Dépatie L, O'Driscoll GA, Holahan AV, et al. Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology. 2002;27:1056-1070.
23. Hong LE, Thaker GK, McMahon RP, et al. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 2011;68:1195-1206.
24. Myers CS, Robles O, Kakoyannis AN, et al. Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology. 2004;174:334-340.
25. Smith RC, Warner-Cohen J, Matute M, et al. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology. 2006;31:637-643.
26. Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.). New Jersey: Lawrence Erlbaum Associates, 1988.
27. Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS. Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry. 2008;165:978-987.
28. Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biol Psychiatry. 2013;74:436-443.
29. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. J Am Med Assoc. 2000;284:2606-2610.